15:59 Dec 15

Panacea Biotec Ltd.

Sector Pharmaceuticals & Biotechnology Industry Biotechnology
Up
357.15
-6.10 (-1.68%)
Sector Pharmaceuticals & Biotechnology Industry Biotechnology

Panacea Biotec Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Biotechnology
Up
357.15
-6.10 (-1.68%)
15:59 Dec 15
Quality
image/svg+xml

21/100
Low Financial Strength

Valuation
image/svg+xml

14/100
Expensive Valuation

Technical

34/100
Technically Bearish

Strength

4

Weakness

8

Opportunity

1

Threats

0

-1.02 %

ROE %

-0.64 %

ROA %

-1.18

EPS

132.76

BVPS

-1.49 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
661.23 459.95 559.17 559.09 603.85
Operating Expenses +
675.1 557.9 579.23 585.01 641.74
Raw Material
311.17 218.29 212.26 221.67 262.87
Increase Decrease in Cost
-48.97 34.37 17.86 -22.13 -12.08
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
182.94 126.48 149.57 173.05 185.54
Miscellaneous Expenses
289.8 193.28 203.14 227.62 205.41
Operating Profit
-13.87 -97.95 -20.06 -25.92 -37.89
Other Income
10.97 51.66 25.8 20.66 24.28
Depreciation
43.66 39.12 36.71 34.81 34.13
Interest
180.84 4.44 3.58 3.88 5.03
Profit before tax and exceptio..
-227.4 -89.86 -34.56 -43.94 -52.77
Exceptional Items
1676.21 102.66 36.03 35.99 44.5
PBT
1448.81 12.8 1.48 -7.95 -97.27
Provision for Taxation
370.9 46.55 2.98 0.77 -0.67
Net Profit
1077.9 -33.74 -1.5 -8.72 -7.6
NET Profit after MI
1077.88 -33.24 -1.17 -8.37 -7.24
EPS
175.98 -5.43 -0.19 -1.37 -1.18
Operating Profit Margin (%)
-2.1 -21.3 -3.59 -4.64 -6.27
Net Profit Margin (%)
163.01 -7.23 -0.21 -1.5 -1.2

Panacea Biotec Ltd. Shareholding

All Data in Percentage (%)

Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Download Our App On: